The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Neuroscience Letters

• Publication date

  1991-07-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0304-3940(91)90258-UPMID 1834964
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors.

  1990cited by this paper
• Interactions between glutamatergic and monoaminergic systems within the basal ganglia--implications for schizophrenia and Parkinson's disease.

  1990cited by this paper
• NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus.

  1990cited by this paper
• NMDA antagonists potentiate antiparkinsonian actions of L‐dopa in monoamine‐depleted rats

  1990cited by this paper
• Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.

  1990cited by this paper
• Interactions of Phencyclidine Receptor Agonist MK‐801 with Dopaminergic System: Regional Studies in the Rat

  1990cited by this paper
• In vivo evidence for an inhibitory glutamatergic control of serotonin release in the cat caudate nucleus: involvement of GABA neurons.

  1990cited by this paper
• NMDA antagonists interact with 5-HT-stimulated phosphatidylinositol metabolism and impair passive avoidance retention in the rat.

  1990cited by this paper
• Handling habituation and chlordiazepoxide have different effects on GABA and 5-HT function in the frontal cortex and hippocampus.

  1990cited by this paper
• Handling habituation and ehlordiazepoxide have different effects on GABA and 5-HT function in the frontal cortex and hippocampus

  1990cited by this paper
• The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.

  1989cited by this paper
• Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine.

  1989cited by this paper
• Presynaptic Receptors on Catecholamine Neurones

  1988cited by this paper
• Simultaneous liquid chromatographic determination of seventeen of the major monoamine neurotransmitters, precursors and metabolites. II. Assessment of human brain and cerebrospinal fluid concentrations.

  1987cited by this paper
• The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist.

  1986cited by this paper
• The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.

  1984cited by this paper
• Development of a synaptosomal model to determine drug-induced in vivo changes in GABA-levels of nerve endings in 11 brain regions of the rat.

  1984cited by this paper
• Serotonergic involvement in phencyclidine-induced behaviors.

  1984cited by this paper
• Changes in catecholamine content in discrete brain nuclei during the estrous cycle of the rat.

  1978cited by this paper
• Diurnal changes in hypothalamic serotonin content and its correlation with adrenal function in the rat during the oestrus cycle.

  1973cited by this paper
• Homovanillic acid levels in rat striatum during the oestrous cycle.

  1973cited by this paper
• Concentration of norepinephrine in the hypothalamus of the rat in relation to the estrous cycle.

  1968cited by this paper
• Central sympathomimetic activity of (+)‐5‐methyl‐10,11‐dihydro‐5H‐dibenzo [a, d]cyclohepten‐5,10‐imine (MK‐801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties

  year unknowncited by this paper

• Heterogeneous brain distribution of bumetanide following systemic administration in rats

  2024cites this paper
• Brain-region-specific changes in neurons and glia and dysregulation of dopamine signaling in Grin2a mutant mice.

  2023cites this paper
• Memantine ameliorates the impairment of social behaviors induced by a single social defeat stress as juveniles.

  2022cites this paper
• NMDAR Hypofunction Animal Models of Schizophrenia

  2019cites this paper
• An assessment of reconsolidation blockade to disrupt memories relevant to psychiatric disorders

  2017cites this paper
• Sex differences in PFC-related behavior after amphetamine exposure and across adolescent development

  2017cites this paper
• Delta-9-Tetrahydrocannabinol and Catalepsy-Like Immobilization

  2017cites this paper
• Mechanisms of action and clinical efficacy of NMDA receptor modulators in mood disorders.

  2017cites this paper
• MK-801 increases locomotor activity in a context-dependent manner in zebrafish.

  2016cites this paper
• Efeito de antagonistas do receptor NMDA sobre a metilação do DNA

  2016cites this paper
• Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters

  2016cites this paper
• Attenuation of MK-801-induced behavioral perseveration by typical and atypical antipsychotic pretreatment in rats.

  2015cites this paper
• A putative rodent model of executive function deficits occurs when rats show impaired behavioral shifting in response to an appetitive extinction procedure

  2015cites this paper
• Effects of amphetamine exposure in adolescence or young adulthood on inhibitory control in adult male and female rats.

  2014cites this paper
• Treadmill exercise enhances NMDA receptor expression in schizophrenia mice

  2014cites this paper
• Hypnotizability and Catechol-O-Methyltransferase (COMT) polymorphysms in Italians

  2014cites this paper
• Reviewing the ketamine model for schizophrenia

  2014cites this paper
• Serotonin receptors as targets for drugs useful to treat psychosis and cognitive impairment in schizophrenia.

  2012cites this paper
• Universidade Federal de Santa Catarina Centro de Ciências Biológicas Programa de Pós-Graduação em Neurociências

  2012cites this paper
• Disruption of Prefrontal Cortex Large Scale Neuronal Activity by Different Classes of Psychotomimetic Drugs

  2012cites this paper
• Altered 13C Glucose Metabolism in the Cortico—Striato—Thalamo—Cortical Loop in the MK-801 Rat Model of Schizophrenia

  2011influential citation
• NMDA and AMPA receptors are involved in the antidepressant-like activity of tianeptine in the forced swim test in mice

  2011cites this paper
• NMDA and AMPA receptors are involved in the antidepressant-like activity of tianeptine in the forced swim test in mice

  2011cites this paper
• Effect of cannabidiol in a MK-801-rodent model of aspects of schizophrenia.

  2011cites this paper
• The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment

  2011cites this paper
• Abnormal circling behavior in rat mutants and its relevance to model specific brain dysfunctions.

  2010cites this paper
• Rat Mutants with Lateralized Rotational Behavior for Studying Disturbances in Cerebral Asymmetries and Their Involvement in Brain Disorders

  2010cites this paper
• Information processing deficits and nitric oxide signalling in the phencyclidine model of schizophrenia

  2010cites this paper
• The effect of the NMDA receptor antagonist dizocilpine on behavioral manifestations of serotonin and adrenergic antidepressants in rats.

  2010cites this paper
• Neuroprotection by adenosine receptors in aged rats - role of neuroinflammation

  2009cites this paper
• 13C NMRS of animal models of schizophrenia

  2009cites this paper
• Evidence for the involvement of the monoaminergic system in the antidepressant-like effect of magnesium.

  2009influential citation
• Delta 9-tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons.

  2008cites this paper
• Altered Excitatory-Inhibitory Balance in the NMDA-Hypofunction Model of Schizophrenia

  2008cites this paper
• Serotonin and epilepsy

  2007cites this paper
• Clozapine prevents a decrease in neurogenesis in mice repeatedly treated with phencyclidine.

  2007cites this paper
• Marked differences in response to dopamine receptor antagonism in two rat mutants, ci2 and ci3, with lateralized rotational behavior.

  2007cites this paper
• Modulation of antidepressant-like activity of magnesium by serotonergic system

  2007cites this paper
• Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.

  2006cites this paper
• Generation of spike wave discharges in absence epilepsy : Modulatory effects of serotonin , glutamate and glycine

  2006cites this paper
• Role of glutamate and dopamine receptors in the psychopharmacological profile of the indole alkaloid psychollatine.

  2006cites this paper
• Mechanism of action of antidepressants: aspects of serotoninergic system and its interaction with glutamate

  2006cites this paper
• Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? (Hypothesis)

  2005cites this paper
• Avaliação do perfil psicofarmacológico de psicolatina isolada de psychotria umbellata (rubiaceae)

  2005cites this paper
• Investigations ofSapindus trifoliatusin dopaminergic and serotonergic systems: Putative antimigraine mechanisms

  2005cites this paper
• Dopamine-glutamate interaction and antipsychotics mechanism of action: implication for new pharmacological strategies in psychosis.

  2005cites this paper
• The synergistic effect of fluoxetine on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist

  2005cites this paper
• Concurrent locomotor stimulation and decrease in dopamine release in rats and mice after treatment with the competitive NMDA receptor antagonists D-CPPene and CGS 19755

  2005cites this paper
• Effects of dopamine D1 and D2 receptor blockade on MK-801-induced hyperlocomotion in rats

  2005cites this paper
• serotoner serotonergic systems: Putative antimigraine mechanisms gic systems: Putative antimigraine mechanisms gic systems: Putative antimigraine mechanisms gic systems: Putative antimigraine mechanisms gic systems: Putative antimigraine mechanisms Research Paper

  2005cites this paper
• Behavioural and neurochemical interactions of the AMPA antagonist GYKI 52466 and the non-competitive NMDA antagonist dizocilpine in rats

  2005cites this paper
• Role of dopaminergic neuronal system in dizocilpine-induced acetylcholine release in the rat brain

  2005cites this paper
• Effect of acute and chronic lamotrigine on basal and stimulated extracellular 5‐hydroxytryptamine and dopamine in the hippocampus of the freely moving rat

  2004cites this paper
• Basal Ganglia and Its Relevance to Parkinson’s Disease

  2004cites this paper
• Effect of two noncompetitive AMPA receptor antagonists GYKI 52466 and GYKI 53405 on vigilance, behavior and spike-wave discharges in a genetic rat model of absence epilepsy.

  2004cites this paper
• The multiple effects of ketamine on electroencephalographic activity and behavior in WAG/Rij rats.

  2004cites this paper
• The influence of adenosine A3 receptor agonist: IB-MECA, on scopolamine- and MK-801-induced memory impairment.

  2003cites this paper
• [Analysis of neuronal functions in mice lacking the NMDA receptor epsilon 1 subunit].

  2002cites this paper
• Adaptation of monoaminergic responses to phencyclidine in nucleus accumbens and prefrontal cortex following repeated treatment with fluoxetine or imipramine.

  2002cites this paper
• Dual serotonin and noradrenaline uptake inhibitor class of antidepressants potential for greater efficacy or just hype?

  2002cites this paper
• Sexually dimorphic effects of morphine and MK-801: sex steroid-dependent and -independent mechanisms.

  2002cites this paper
• Current perspectives on the development of non-biogenic amine-based antidepressants.

  2001cites this paper
• 8-OH-DPAT and MK-801 affect epileptic activity independently of vigilance.

  2001cites this paper
• Hyperfunction of Dopaminergic and Serotonergic Neuronal Systems in Mice Lacking the NMDA Receptor ε1 Subunit

  2001cites this paper
• Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor epsilon1 subunit.

  2001cites this paper
• A novel black-hooded mutant rat (ci3) with spontaneous circling behavior but normal auditory and vestibular functions.

  2001cites this paper
• Delayed onset of enhanced MK-801-induced motor hyperactivity after neonatal lesions of the rat ventral hippocampus.

  2001cites this paper
• Effects of dizocilpine (MK 801) on noradrenaline, serotonin and dopamine release and uptake

  2000cites this paper
• Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT(2C/2B) receptor antagonists: neurochemical and behavioural studies.

  2000cites this paper
• The effect of ketamine isomers on both mice behavioral responses and c-Fos expression in the posterior cingulate and retrosplenial cortices.

  2000cites this paper
• Exaggerated MK‐801‐induced motor hyperactivity in rats with the neonatal lesion of the ventral hippocampus

  2000cites this paper
• N‐Methyl‐d‐aspartate Receptor Antagonists Enhance the Head‐twitch Response, a 5‐Hydroxytryptamine2 Receptor‐mediated Behaviour, in Reserpine‐treated Mice

  2000cites this paper
• Repeated Phencyclidine Treatment Induces Negative Symptom-like Behavior in Forced Swimming Test in Mice: Imbalance of Prefrontal Serotonergic and Dopaminergic Functions

  2000cites this paper
• WAY 100135, an Antagonist of 5-HT1A Serotonin Receptors, Attenuates Psychotomimetic Effects of MK-801

  2000influential citation
• Sexual dimorphism in the response to N-methyl-D-aspartate receptor antagonists and morphine on behavior and c-Fos induction in the rat brain.

  1999cites this paper
• Blockade of the acquisition of ethanol-induced conditioned place preference by N-methyl-D-aspartate receptor antagonists.

  1999cites this paper
• NMDA receptor antagonism produces antinociception which is partially mediated by brain opioids and dopamine.

  1999cites this paper
• MK-801 administration blocks the effects of a 5-HT(2A/2C) agonist on melatonin rhythmicity and c-fos induction in the suprachiasmatic nucleus.

  1999cites this paper
• Destruction of the noradrenergic system with DSP4 potentiates the behavioral effects of MK-801 in rats.

  1999cites this paper
• Effects of the NMDA/glycine receptor antagonist, L-701,324, on morphine- and cocaine-induced place preference.

  1999cites this paper
• The rewarding properties of NMDA and MK-801 (dizocilpine) as indexed by the conditioned place preference paradigm.

  1999cites this paper
• NMDA receptor antagonists inhibit apomorphine-induced climbing behavior not only in intact mice but also in reserpine-treated mice.

  1999cites this paper
• Immunohistochemical and neurochemical studies on nigral and striatal functions in the circling (ci) rat, a genetic animal model with spontaneous rotational behavior.

  1999cites this paper
• NMDA receptor antagonists enhance 5-HT2 receptor-mediated behavior, head-twitch response, in PCPA-treated mice

  1999cites this paper
• Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats.

  1999cites this paper
• MK‐801 interaction with the 5‐HT transporter: a real‐time study in brain slices using fast cyclic voltammetry

  1999cites this paper
• Effects of the NMDA receptor antagonist D-CPPene on extracellular levels of dopamine and dopamine and serotonin metabolites in striatum of kindled and non-kindled rats.

  1999cites this paper
• Antidepressants for the new millennium.

  1999cites this paper
• Dopamine and serotonin imbalances in the left anterior cingulate and pyriform cortices following the repeated intermittent administration of cocaine.

  1999cites this paper
• A serotonin-1A receptor agonist and an N-methyl-D-aspartate receptor antagonist oppose each others effects in a genetic rat epilepsy model.

  1999cites this paper
• Chronic ethanol consumption: from neuroadaptation to neurodegeneration.

  1998cites this paper
• Dopamine release in the nucleus accumbens and latent inhibition in the rat following microinjections of a 5 -HT1B agonist into the dorsal subiculum: implications for schizophrenia

  1998cites this paper
• Rodent data and general hypothesis: antipsychotic action exerted through 5-HT2A receptor antagonism is dependent on increased serotonergic tone

  1998cites this paper
• Enhanced [3H]DOPA and [3H]Dopamine Turnover in Striatum and Frontal Cortex In Vivo Linked to Glutamate Receptor Antagonism

  1998cites this paper
• The role of striatal dopaminergic mechanisms in rotational behavior induced by phencyclidine and phencyclidine-like drugs

  1998cites this paper
• 5-HT2A receptor antagonists block MK-801-induced stereotypy and hyperlocomotion.

  1998cites this paper
• NMDA receptors mediate lasting increases in anxiety-like behavior produced by the stress of predator exposure--implications for anxiety associated with posttraumatic stress disorder.

  1998cites this paper
• Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy.

  1998cites this paper
• Differential effects of NMDA and non-NMDA antagonists on the activity of aromatic L-amino acid decarboxylase activity in the nigrostriatal dopamine pathway of the rat.

  1998cites this paper
• NMDA receptor antagonists enhance 5-HT2 receptor-mediated behavior, head-twitch response, in mice.

  1998cites this paper